Gordon C, Graf M, Hopley C, Jennings P, Littlewood M
Diabetes Ther. 2025; .
PMID: 39969756
DOI: 10.1007/s13300-024-01686-4.
Biester T, Berget C, Boughton C, Cudizio L, Ekhlaspour L, Hilliard M
Horm Res Paediatr. 2024; 97(6):636-662.
PMID: 39657603
PMC: 11854989.
DOI: 10.1159/000543034.
Yesil F, Covener Ozcelik C
Balkan Med J. 2024; 41(4):261-271.
PMID: 38829237
PMC: 11588899.
DOI: 10.4274/balkanmedj.galenos.2024.2024-2-115.
Al Hayek A, Al Dawish M
Curr Diabetes Rev. 2024; 21(6):75-92.
PMID: 38676508
DOI: 10.2174/0115733998295755240416060913.
Cavallo M, De Fano M, Barana L, Dozzani I, Bianchini E, Pellegrino M
Nutrients. 2024; 16(6).
PMID: 38542818
PMC: 10975101.
DOI: 10.3390/nu16060907.
Safety and effectiveness of Medtronic MiniMed™ 780G in a neonate with transient neonatal diabetes mellitus: a case report.
Delvecchio M, Panza R, Schettini F, Piccinno E, Laforgia N
Acta Diabetol. 2024; 61(4):529-532.
PMID: 38197960
DOI: 10.1007/s00592-023-02212-x.
Dual-basal-insulin regimen for the management of dawn phenomenon in children with type 1 diabetes: a retrospective cohort study.
Celik N, Emet D, Canturk M, Ozon Z, Gonc E
Ther Adv Endocrinol Metab. 2023; 14:20420188231220130.
PMID: 38152658
PMC: 10752105.
DOI: 10.1177/20420188231220130.
Responses to the Strengths and Difficulties Questionnaire predict HbA1c trajectories in children and adolescents with type 1 diabetes: a population-based study.
Marks K, Pouwer F, Jensen M, Ibfelt E, Kristensen L, Thastum M
BMJ Open Diabetes Res Care. 2023; 11(6).
PMID: 37914346
PMC: 10626890.
DOI: 10.1136/bmjdrc-2023-003479.
Pediatric Diabetes Technology Management: An Italian Exploratory Study on Its Representations by Psychologists and Diabetologists.
Tupputi A, Giardinieri L, Monaco S, Di Trani M
Eur J Investig Health Psychol Educ. 2023; 13(5):919-931.
PMID: 37232708
PMC: 10217315.
DOI: 10.3390/ejihpe13050070.
Barriers to Uptake of Open-Source Automated Insulin Delivery Systems: Analysis of Socioeconomic Factors and Perceived Challenges of Caregivers of Children and Adolescents With Type 1 Diabetes From the OPEN Survey.
Huhndt A, Chen Y, ODonnell S, Cooper D, Ballhausen H, Gajewska K
Front Clin Diabetes Healthc. 2023; 3:876511.
PMID: 36992765
PMC: 10012142.
DOI: 10.3389/fcdhc.2022.876511.
Development and design of the first structured clinic-based program in lower resource settings to transition emerging adults with type 1 diabetes from pediatric to adult care.
Cristello Sarteau A, Peerzada A, Goyal A, Praveen P, Tandon N
PLOS Glob Public Health. 2023; 2(8):e0000665.
PMID: 36962558
PMC: 10021365.
DOI: 10.1371/journal.pgph.0000665.
Narrowing the Divide: The Role of Telehealth in Type 1 Diabetes Care for Marginalized Communities.
Crossen S, Wagner D
J Diabetes Sci Technol. 2023; 17(4):901-908.
PMID: 36896887
PMC: 10348000.
DOI: 10.1177/19322968231157367.
Factors Associated With Achieving Target A1C in Children and Adolescents With Type 1 Diabetes: Findings From the T1D Exchange Quality Improvement Collaborative.
Demeterco-Berggren C, Ebekozien O, Noor N, Rompicherla S, Majidi S, Jones N
Clin Diabetes. 2023; 41(1):68-75.
PMID: 36714245
PMC: 9845079.
DOI: 10.2337/cd22-0073.
Time in Range in Children with Type 1 Diabetes before and during a Diabetes Camp-A Ceiling Effect?.
Nagl K, Bozic I, Berger G, Tauschmann M, Blauensteiner N, Weimann K
Children (Basel). 2022; 9(12).
PMID: 36553394
PMC: 9777517.
DOI: 10.3390/children9121951.
Insulin Pump Therapy Efficacy and Key Factors Influencing Adherence in Pediatric Population-A Narrative Review.
Trandafir L, Moisa S, Vlaiculescu M, Butnariu L, Boca L, Leon Constantin M
Medicina (Kaunas). 2022; 58(11).
PMID: 36422210
PMC: 9699426.
DOI: 10.3390/medicina58111671.
Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits.
Pauley M, Tommerdahl K, Snell-Bergeon J, Forlenza G
Curr Cardiol Rep. 2022; 24(12):2043-2056.
PMID: 36279036
PMC: 9589770.
DOI: 10.1007/s11886-022-01799-x.
Assessing Incorporation of Type 1 Diabetes Into Identity: Validation of the Accepting Diabetes and Personal Treatment (ADAPT) Survey in Teens and Young Adults.
Commissariat P, Volkening L, Weinzimer S, Dassau E, Laffel L
Can J Diabetes. 2022; 47(1):66-72.
PMID: 36184368
PMC: 10096441.
DOI: 10.1016/j.jcjd.2022.08.007.
CONTINUOUS GLUCOSE MONITORING AND TYPE 1 DIABETES MELLITUS CONTROL IN CHILD, ADOLESCENT AND YOUNG ADULT POPULATION - ARGUMENTS FOR ITS USE AND EFFECTS.
Rubelj K, Stipancic G, Sabolic L, Pozgaj Sepec M
Acta Clin Croat. 2022; 60(4):609-616.
PMID: 35734487
PMC: 9196217.
DOI: 10.20471/acc.2021.60.04.07.
Insulin pump therapy is associated with higher rates of mild diabetic ketoacidosis compared to injection therapy: A 2-year Swedish national survey of children and adolescents with type 1 diabetes.
Wersall J, Adolfsson P, Forsander G, Hanas R
Pediatr Diabetes. 2022; 23(7):1038-1044.
PMID: 35678764
PMC: 9796597.
DOI: 10.1111/pedi.13377.
Comparison of the clinical effects of intermittently scanned and real-time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study.
Urakami T, Terada H, Yoshida K, Kuwabara R, Mine Y, Aoki M
J Diabetes Investig. 2022; 13(10):1745-1752.
PMID: 35532954
PMC: 9533045.
DOI: 10.1111/jdi.13830.
